about
Angiogenic factors in preeclampsia: potential for diagnosis and treatmentAngiogenic proteins as aid in the diagnosis and prediction of preeclampsia.New developments in the pathogenesis of preeclampsiaRetrospective study of risk factors and maternal and fetal outcome in patients with abruptio placentaeAngiogenic factors and preeclampsia.New-onset maternal gestational hypertension and risk of retinopathy of prematurity.Midpregnancy levels of angiogenic markers in relation to maternal characteristics.Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthResponse to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy.Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective StudyA prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsiaIschemic placental syndrome--prediction and new disease monitoring.Understanding biological mechanisms underlying adverse birth outcomes in developing countries: protocol for a prospective cohort (AMANHI bio-banking) study.Biochemical markers of placental dysfunction in assisted conception.Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
P2860
Q26825774-757655CB-BF22-4147-9062-861759A0B745Q33349183-66F84475-B932-4B6A-8A7E-CAC534E0DF5EQ33935675-ECF7A194-71B2-4520-A0FD-8EEE46118A93Q34002936-B075717F-548D-495E-A74A-87EDEE7825ADQ34714082-090B0C2F-6130-4190-A340-987B8093C32AQ34735110-79C6DC85-C954-48B3-93F7-87D0443A4C60Q34821237-F0C0B690-CC78-4A75-A3E1-AA69E8A58CFAQ35143007-466FC199-D450-451A-8A51-6763F3B332B8Q35314203-BB794265-FE3E-4F46-AA30-E5D259716F2FQ36043513-E98BFA08-8FD4-4863-BA6C-865CA625E0FDQ36051943-312F78AB-B903-4DFE-8869-4A215AE84C3DQ36189562-4809997F-A6EC-4935-9C40-B4997B92BEECQ38601408-029FD9BD-86F8-4018-970A-B99C105F4F8BQ43923824-50AC905C-B07A-47B2-9B73-1D0631A46530Q48717665-4AA802CF-1133-4969-AC04-0C8D0EF829E1Q55003601-6955AD91-F0B3-4692-9DBE-6C4B73434F30
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Circulating soluble endoglin and placental abruption.
@en
type
label
Circulating soluble endoglin and placental abruption.
@en
prefLabel
Circulating soluble endoglin and placental abruption.
@en
P2093
P2860
P356
P1433
P1476
Circulating soluble endoglin and placental abruption.
@en
P2093
Caroline Signore
James L Mills
Richard J Levine
Sarosh Rana
P2860
P304
P356
10.1002/PD.2065
P577
2008-09-01T00:00:00Z